Prospective Trial Comparing the Use of Sulphasalazine and Auranofin as Second Line Drugs in Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.51.4.461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Sulphasalazine in Rheumatoid Arthritis.

BMJ
1980English

Sulphasalazine in Rheumatoid Arthritis.

BMJ
1983English

Macrocytic Anaemia in Patients Treated With Sulphasalazine for Rheumatoid Arthritis.

BMJ
1986English

Sulphasalazine in Rheumatoid Arthritis: Desensitising the Patient With a Skin Rash.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1986English

A Long-Term Five-Year Randomized Controlled Trial of Hydroxychloroquine, Sodium Aurothiomalate, Auranofin and Penicillamine in the Treatment of Patients With Rheumatoid Arthritis

Rheumatology
RheumatologyPharmacology
1998English

MTX Use in Japanese Patients With Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2018English

Etanercept: Therapeutic Use in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1999English

Trial Comparing D-Penicillamine and Gold in Rheumatoid Arthritis. Preliminary Report.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1974English

Cost-Effectiveness of Abatacept, Tocilizumab and TNF-inhibitors Compared With Rituximab as Second-Line Biologic Drug in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy